Molecular probes for the in vivo imaging of cancer

被引:52
作者
Alford, Raphael [1 ,2 ]
Ogawa, Mikako [1 ]
Choyke, Peter L. [1 ]
Kobayashi, Hisataka [1 ]
机构
[1] NCI, Mol Imaging Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] Case Western Reserve Sch Med, Cleveland, OH USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; FLUORESCENCE LIFETIME SPECTROSCOPY; MAGNETIC-RESONANCE; FDG-PET; BREAST-CANCER; F-18-FLT PET; RESPONSE ASSESSMENT; TUMOR-CELLS; LYMPH-NODES; PHASE-I;
D O I
10.1039/b911307j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Advancements in medical imaging have brought about unprecedented changes in the in vivo assessment of cancer. Positron emission tomography, single photon emission computed tomography, optical imaging, and magnetic resonance imaging are the primary tools being developed for oncologic imaging. These techniques may still be in their infancy, as recently developed chemical molecular probes for each modality have improved in vivo characterization of physiologic and molecular characteristics. Herein, we discuss advances in these imaging techniques, and focus on the major design strategies with which molecular probes are being developed.
引用
收藏
页码:1279 / 1291
页数:13
相关论文
共 136 条
[51]   Early response assessment using 3′-Deoxy-3′-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma [J].
Herrmann, Ken ;
Wieder, Hinrich A. ;
Buck, Andreas K. ;
Schoeffel, Marion ;
Krause, Bernd-Joachim ;
Fend, Falko ;
Schuster, Tibor ;
zum Bueschenfeld, Christian Meyer ;
Wester, Hans-Juergen ;
Duyster, Justus ;
Peschel, Christian ;
Schwaiger, Markus ;
Dechow, Tobias .
CLINICAL CANCER RESEARCH, 2007, 13 (12) :3552-3558
[52]   FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features [J].
Higashi, K ;
Ueda, Y ;
Ayabe, K ;
Sakurai, A ;
Seki, H ;
Nambu, Y ;
Oguchi, M ;
Shikata, H ;
Taki, S ;
Tonami, H ;
Katsuda, S ;
Yamamoto, I .
NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (08) :707-714
[53]   Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma [J].
Juweid, Malik E. ;
Stroobants, Sigrid ;
Hoekstra, Otto S. ;
Mottaghy, Felix M. ;
Dietlein, Markus ;
Guermazi, Ali ;
Wiseman, Gregory A. ;
Kostakoglu, Lale ;
Scheidhauer, Klemens ;
Buck, Andreas ;
Naumann, Ralph ;
Spaepen, Karoline ;
Hicks, Rodney J. ;
Weber, Wolfgang A. ;
Reske, Sven N. ;
Schwaiger, Markus ;
Schwartz, Lawrence H. ;
Zijlstra, Josee M. ;
Siegel, Barry A. ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :571-578
[54]   Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A) [J].
Kehagias, DT ;
Gouliamos, AD ;
Smyrniotis, V ;
Vlahos, LJ .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2001, 14 (05) :595-601
[55]   Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development [J].
Kelloff, G ;
Hoffman, JM ;
Johnson, B ;
Scher, HI ;
Siegel, BA ;
Cheng, EY ;
Cheson, BD ;
O'Shaughnessy, J ;
Guyton, KZ ;
Mankoff, DA ;
Shankar, L ;
Larson, SM ;
Sigman, CC ;
Schilsky, RL ;
Sullivan, DC .
CLINICAL CANCER RESEARCH, 2005, 11 (08) :2785-2808
[56]   Imaging early changes in proliferation at 1 week post chemotherapy:: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography [J].
Kenny, Laura ;
Coombes, R. Charles ;
Vigushin, David M. ;
Al-Nahhas, Adil ;
Shousha, Sami ;
Aboagye, Eric O. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (09) :1339-1347
[57]  
Kersemans V, 2005, J NUCL MED, V46, P532
[58]   Cancer's molecular sweet tooth and the Warburg effect [J].
Kim, Jung-whan ;
Dang, Chi V. .
CANCER RESEARCH, 2006, 66 (18) :8927-8930
[59]   Multimodality Assessment of Esophageal Cancer: Preoperative Staging and Monitoring of Response to Therapy [J].
Kim, Tae Jung ;
Kim, Hyae Young ;
Lee, Kyung Won ;
Kim, Moon Soo .
RADIOGRAPHICS, 2009, 29 (02) :403-U130
[60]   Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent [J].
Kobayashi, H ;
Kawamoto, S ;
Sakai, Y ;
Choyke, PL ;
Star, RA ;
Brechbiel, MW ;
Sato, N ;
Tagaya, Y ;
Morris, JC ;
Waldmann, TA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (09) :703-708